Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic
During 2020–2021, countries in Latin America and the Caribbean reported clinical emergence of carbapenemase-producing Enterobacterales that had not been previously characterized locally, increased prevalence of carbapenemases that had previously been detected, and co-production of multiple carbapenemases in some isolates. These increases were likely fueled by changes related to the COVID-19 pandemic, including empirical antibiotic use for potential COVID-19–related bacterial infections and healthcare limitations resulting from the rapid rise in COVID-19 cases. Strengthening antimicrobial resistance surveillance, epidemiologic research, and infection prevention and control programs and antimicrobial stewardship in clinical settings can help prevent emergence and transmission of carbapenemase-producing Enterobacterales..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Emerging Infectious Diseases - 28(2022), 11, Seite 8 |
| Sprache: |
Englisch |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.3201/eid2811.220415 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ028027655 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ028027655 | ||
| 003 | DE-627 | ||
| 005 | 20230307122655.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3201/eid2811.220415 |2 doi | |
| 035 | |a (DE-627)DOAJ028027655 | ||
| 035 | |a (DE-599)DOAJ30c3a9a6c93848638a77493a5e7160e2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Genara Romero Thomas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a During 2020–2021, countries in Latin America and the Caribbean reported clinical emergence of carbapenemase-producing Enterobacterales that had not been previously characterized locally, increased prevalence of carbapenemases that had previously been detected, and co-production of multiple carbapenemases in some isolates. These increases were likely fueled by changes related to the COVID-19 pandemic, including empirical antibiotic use for potential COVID-19–related bacterial infections and healthcare limitations resulting from the rapid rise in COVID-19 cases. Strengthening antimicrobial resistance surveillance, epidemiologic research, and infection prevention and control programs and antimicrobial stewardship in clinical settings can help prevent emergence and transmission of carbapenemase-producing Enterobacterales. | ||
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a respiratory infections | |
| 650 | 4 | |a severe acute respiratory syndrome coronavirus 2 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a SARS | |
| 650 | 4 | |a coronavirus disease | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Alejandra Corso |e verfasserin |4 aut | |
| 700 | 0 | |a Fernando Pasterán |e verfasserin |4 aut | |
| 700 | 0 | |a Justina Shal |e verfasserin |4 aut | |
| 700 | 0 | |a Aldo Sosa |e verfasserin |4 aut | |
| 700 | 0 | |a Marcelo Pillonetto |e verfasserin |4 aut | |
| 700 | 0 | |a Renata Tigulini de Souza Peral |e verfasserin |4 aut | |
| 700 | 0 | |a Juan Carlos Hormazábal |e verfasserin |4 aut | |
| 700 | 0 | |a Pamela Araya |e verfasserin |4 aut | |
| 700 | 0 | |a Sandra Yamile Saavedra |e verfasserin |4 aut | |
| 700 | 0 | |a Mariá Victoria Ovalle |e verfasserin |4 aut | |
| 700 | 0 | |a María Antonieta Jiménez Pearson |e verfasserin |4 aut | |
| 700 | 0 | |a Grettel Chanto Chacón |e verfasserin |4 aut | |
| 700 | 0 | |a Eric Carbon |e verfasserin |4 aut | |
| 700 | 0 | |a Carmen Julia Mazariegos Herrera |e verfasserin |4 aut | |
| 700 | 0 | |a Selene del Carmen González Velásquez |e verfasserin |4 aut | |
| 700 | 0 | |a Carolina Satan-Salazar |e verfasserin |4 aut | |
| 700 | 0 | |a Fernando Villavicencio |e verfasserin |4 aut | |
| 700 | 0 | |a Nancy Melgarejo Touchet |e verfasserin |4 aut | |
| 700 | 0 | |a Sofía Busignani |e verfasserin |4 aut | |
| 700 | 0 | |a Maritza Mayta-Barrios |e verfasserin |4 aut | |
| 700 | 0 | |a Juan Ramírez-Illescas |e verfasserin |4 aut | |
| 700 | 0 | |a Mariana López Vega |e verfasserin |4 aut | |
| 700 | 0 | |a Cristina Mogdasy |e verfasserin |4 aut | |
| 700 | 0 | |a Verónica Rosas |e verfasserin |4 aut | |
| 700 | 0 | |a Nuris Salgado |e verfasserin |4 aut | |
| 700 | 0 | |a Rodolfo Quiroz |e verfasserin |4 aut | |
| 700 | 0 | |a Nathalie El-Omeiri |e verfasserin |4 aut | |
| 700 | 0 | |a Marcelo Fabián Galas |e verfasserin |4 aut | |
| 700 | 0 | |a Pilar Ramón-Pardo |e verfasserin |4 aut | |
| 700 | 0 | |a Roberto Gustavo Melano |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Emerging Infectious Diseases |d Centers for Disease Control and Prevention, 2003 |g 28(2022), 11, Seite 8 |w (DE-627)DOAJ000014966 |x 10806059 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2022 |g number:11 |g pages:8 |
| 856 | 4 | 0 | |u https://doi.org/10.3201/eid2811.220415 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/30c3a9a6c93848638a77493a5e7160e2 |z kostenfrei |
| 856 | 4 | 0 | |u https://wwwnc.cdc.gov/eid/article/28/11/22-0415_article |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1080-6040 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1080-6059 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2022 |e 11 |h 8 | ||